A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-014-2576-8
Published Online: 2014-09-12
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mateo, J.
Berlin, J.
de Bono, J. S.
Cohen, R. B.
Keedy, V.
Mugundu, G.
Zhang, Lianglin
Abbattista, A.
Davis, C.
Gallo Stampino, C.
Borghaei, H.
License valid from 2014-09-12